Navigation Links
Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech

A self-made billionaire has announced a gift of $2 million to Virginia Tech, even though he did not complete his graduation from that college of engineering. //

His philanthropy is the result of a long-term relationship with Paul and Dot Torgersen of Blacksburg, Va. When he was a youngster, he used to mow the Torgersen's lawn for some spending money. Today, that young man is the Chairman and Chief Executive Officer of Google, and according to some accounts, a possible candidate for Time Magazine's next Person of the Year. His name is Eric E. Schmidt.

Last spring, Paul Torgersen, president of Virginia Tech from 1993 until 2000 and dean of its College of Engineering from 1970 to 1990, visited Schmidt in California, the home of Google. Over breakfast they discussed the possibility of Schmidt funding an endowed dean’s chair that would enhance the already attractive leadership position of Virginia Tech's highly ranked College of Engineering.

When Torgersen made the proposal, he suggested to his former neighbor that the gift be named the Eric Schmidt Dean's Chair in Engineering at Virginia Tech. Recently, Eric and his wife, Wendy, agreed to fund this proposal, the largest philanthropic gift they have made to date.

But they had a caveat unknown to Torgersen. When the legal document was completed, the Schmidts request was to name the chair the Paul and Dorothea Torgersen Dean's Chair in Engineering.

Richard Benson, the current Dean of Engineering at Virginia Tech, informed the Torgersen of this change at the request of the Schmidts.

'I was stunned. I still am,' Torgersen said. 'Dot and I have had some nice things happen to us over the past 52 years, but I do believe this is one of the nicest. The chair is a capstone both for the college and Dot and myself.'

In an email to Torgersen after the surprise twist, Schmidt wrote, 'This seemed to be the least Wendy and I could do to honor your and Dot's commitment
'"/>




Page: 1 2 3

Related medicine news :

1. Billionaire’s Pet Projec
2. What Makes Teens take Drugs
3. Music Makes you Smarter
4. New Healthy Weight Program Makes Healthy Eating More Interesting
5. All Work And No Play Makes Jack A Dull Boy
6. Dieting Makes People Miserable
7. Passive Smoking Makes Kids Prone To Respiratory Illness
8. ‘Never Say Die’ Spirit of Visually Challenged - Makes Him a Role Modl
9. Slash In Medi-Cal Coverage Makes Medical Care For The Poor Questionable
10. Grapefruit Aroma Makes Women Appear Younger
11. Drug Name Confusion Makes Imports Dangerous: FDA

Post Your Comments:
(Date:11/30/2009)...ov. 30 EMD Serono, an affiliate of...hat it received a refuse to file letter from the U...ug Application (NDA) for Cladribine Tablets, EMD S...on of cladribine, as a therapy for relapsing forms...ill work closely with the FDA to fully understand ...
(Date:11/30/2009)... still end up being swallowed, study finds , ... beverage cans -- the kind that stay attached once...n, who can swallow the tabs and damage their diges...hree decades ago, beverage makers starting using w...h were believed to pose a swallowing hazard for ch...
(Date:11/30/2009)...PC has released an online service that lets users ...his is the first hosted service in the world that ...am. Result, blazing fast performance even over slo...Clara, CA (PRWEB) November 30, 2009 -- ShowMyPC ha...Service that uses the familiar Microsoft Remote De...
(Date:11/30/2009)...ses Staten Island courtroom to recreate scene of a...responsible for client’s accident. , ...30, 2009 -- A Staten Island, N.Y. jury awarded a v... who was injured at a New York City construction s...n Construction Company et al (Index No. 102557/05,...
(Date:11/30/2009)...o, November 30 Simbionix USA Corpo...imulation systems, in collaboration,with GORE Medi...l Studio(TM),workshop for the first time at the up... The Simbionix PROcedure Rehearsal Studio(TM) i...inicians to create practice scenarios based on the...
Breaking Medicine News(10 mins):Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:Beverage Can Tabs Remain a Risk for Kids 2Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3
...nounced today new compact,ProSound ultrasound Syst...,European Federation of Societies for Ultrasound i...2008, in Timisoara, Romania. The ProSound 2 is a,p...e premium models of the ProSound series are incorp...
...Orphan Therapeutics today,announced that it has be...essin) New Drug Application (NDA) for the treatmen... with late-stage liver cirrhosis.,LUCASSIN(R) had ... is approved in the U.S. to treat HRS type 1, a,ra...
...uthor and psychologist Dr. Jed,Baker will discuss ...rders,during a conference co-sponsored by the Penn...h of a series of eight conferences by distinguishe...ombetta, CEO of the Pennsylvania Cyber Charter Sch...
... - Preliminary Proxy Results,...Corporation (NYSE: LDG ) today announced a cash d...008 Annual Meeting of Stockholders., The Board of...rs of record at the close of business on June 3,20...
...m Effects of $35 Cost Per Metric Ton of CO2 ...sible, PITTSBURGH, May 28 As recent judicial, po...ue to move the United States toward a,mandatory pr...-term effects of establishing such a cost. The res...
...N.V. (NYSE: HOO ) ("the,Company"), a leading prov...ntries, today announced that it plans to present a...ference at the Sheraton New York Hotel &,Towers in...ss and financial highlights, and will be available...
Other Medicine News:Health News:ALOKA to Unveil a New Compact 'ProSound' Diagnostic Ultrasound System 2Health News:Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1 2Health News:Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1 3Health News:Autism Author and Psychologist Dr. Jed Baker to Speak on Communication Disorders 2Health News:Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders 2Health News:Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows 2Health News:Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows 3
(Date:11/29/2009)...GO, Nov. 30 Elastography is an eff...reast ultrasound, helps distinguish cancerous brea...going study presented today at the annual meeting ...). ,, When mammography yields suspicious findin...tional information. However, ultrasound has the po...
(Date:11/29/2009)...HICAGO, Nov. 29 Royal Philips Elec...nse to an industry need by showing its portfolio o...is year,s 95th annual meeting of the Radiological ...his year from Philips are several advancements and...dose radiation and streamlining workflow to expand...
(Date:11/29/2009)...GO, Nov. 29 Stimulated by the ten ...Fujifilm Medical Systems USA announced today, at t...nual meeting, the formation of its Medical Inform...ms, this new group will integrate all functions as...nd creates a platform for future growth. ,, Sev...
Breaking Medicine Technology:Elastography Reduces Unnecessary Breast Biopsies 2Elastography Reduces Unnecessary Breast Biopsies 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Robert Brady 28D PA 1 29 Chaka Fattah 28D PA 2 29 Kathy Dahlkemper 28D PA 3 29 Joe Sestak 28D PA 7 29 Patrick Murphy 28D PA 8 29 Christopher 60908 1Robert Brady 28D PA 1 29 Chaka Fattah 28D PA 2 29 Kathy Dahlkemper 28D PA 3 29 Joe Sestak 28D PA 7 29 Patrick Murphy 28D PA 8 29 Christopher 60908 2Hollywood Stars Joined in a Celebration of Babies 60906 1Hollywood Stars Joined in a Celebration of Babies 60906 2Hollywood Stars Joined in a Celebration of Babies 60906 3Indiana U at APHA 3A Studies about health education for people with ID stability balls at work 10651 1Indiana U at APHA 3A Studies about health education for people with ID stability balls at work 10651 2Indiana U at APHA 3A Studies about health education for people with ID stability balls at work 10651 3
...RNewswire/ -- DNA Therapeutics,S.A. an emerging ph...cer therapy announces today the elucidation of a n... biomarker of its,first-in-class antitumoral lead ...ming American Association for Cancer,Research annu...ine.,The presentation itself will be available fro...
...ented on Valopicitabine Combined,with an Investiga... 12, 2007 /PRNewswire-FirstCall/ --,Idenix Pharmac...ase,IIb studies of the novel combination of valopi...(Pegasys(R)) in both treatment-naive,and treatment...1,strain of the hepatitis C virus (HCV). These dat...
Other Medicine Technology:DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 2DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7
Lieberman Wire Angled Speculum
Needle Holder (Without Lock)
Chopper / Manipulator
Capsule polisher
Medicine Products: